美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

ARS PHARMACEUTICALS INC

14.88

+0.0000

盤後：14.900.0201+0.14%19:58 EDT

成交量：155.04萬

成交額：2,300.49萬

市值：14.60億

市盈率：186.00

高：15.09

開：14.79

低：14.43

收：14.88

資料載入中...

總覽公司新聞公告

Ars Pharmaceuticals, Inc.盤中異動早盤股價大漲5.48%

Ars Pharmaceuticals, Inc.盤中異動快速拉昇5.60%報13.02美元

Ars Pharmaceuticals, Inc.盤中異動急速下跌5.07%報12.18美元

Ars Pharmaceuticals, Inc.2024財年實現淨利潤8.00百萬美元，同比增加114.71%

BUZZ-美國股市動態-KKR、Micron Technology、Eli Lilly

BUZZ-第四季度利潤意外增長，ARS Pharma股價上漲

異動解讀 | ARS製藥盤中大漲20.34%，季度業績遠超預期

ARS Pharmaceuticals Inc.公佈截至12月31日的季度業績——收益彙總

ARS Pharmaceuticals(SPRY.US)：2024年Q4財報實現營收8660萬美元，前值為0美元，預期值為1590萬美元；每股收益為0.48美元，前值為-0.07美元，預期值為-0.12美元。

異動解讀 | ARS製藥公司業績超預期，股價盤前大漲9.44%

ARS Pharmaceuticals 2024年第四季度非GAAP每股收益為0.48美元，可能與-(0.14)美元預期不具可比性，銷售額為86.60百萬美元，可能與15.82百萬美元預期不具可比性

ARS Pharmaceuticals(SPRY.US)獲Scotiabank首次覆蓋，給予跑贏大盤評級, 目標價30.00美元。

嗡嗡聲--美國股票走勢-CoreCivic、Teladoc、Dynavax

嗡嗡聲--美國股票走勢-Scienture、ARS Pharma、BrightSpring Health

BUZZ-ARS Pharma 因過敏反應鼻噴霧劑在美國獲批範圍擴大而上漲

美國 FDA 擴大 ARS 製藥公司過敏反應鼻噴霧劑在 15-30 公斤患者中的使用範圍

美國 FDA 擴大過敏反應鼻腔噴霧劑在 15-30 公斤體重人羣中的使用範圍

Ars Pharmaceuticals, Inc.盤中異動下午盤股價大漲5.01%報10.69美元

Ars Pharmaceuticals, Inc.盤中異動早盤股價大漲5.57%報10.80美元

Ars Pharmaceuticals, Inc.盤中異動股價大跌5.16%報10.66美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/SPRY/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SPRY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPRY\",,,,,undefined,":{"symbol":"SPRY","market":"US","secType":"STK","nameCN":"ARS PHARMACEUTICALS INC","latestPrice":14.88,"timestamp":1744920000000,"preClose":14.88,"halted":0,"volume":1550448,"hourTrading":{"tag":"盘后","latestPrice":14.9001,"preClose":14.88,"latestTime":"19:58 EDT","volume":3253,"amount":48409.96,"timestamp":1744934336455},"delay":0,"floatShares":47453121,"shares":98119804,"eps":0.079999,"marketStatus":"耶穌受難日休市","change":0,"latestTime":"04-17 16:00:00 EDT","open":14.79,"high":15.09,"low":14.43,"amount":23004851.272848,"amplitude":0.044355,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.079999,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"listingDate":1607058000000,"exchange":"NASDAQ","adjPreClose":14.88,"preHourTrading":{"tag":"盘前","latestPrice":14.99,"preClose":14.88,"latestTime":"09:25 EDT","volume":4,"amount":59.96,"timestamp":1744896306338},"postHourTrading":{"tag":"盘后","latestPrice":14.9001,"preClose":14.88,"latestTime":"19:58 EDT","volume":3253,"amount":48409.96,"timestamp":1744934336455},"volumeRatio":0.9551793844045056,"impliedVol":1.0095,"impliedVolPercentile":0.8805},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPRY\",,,,,undefined,":{"symbol":"SPRY","floatShares":47453121,"roa":"-0.66%","roe":"3.28%","lyrEps":0.082507,"volumeRatio":0.9551793844045056,"shares":98119804,"dividePrice":0,"high":15.09,"amplitude":0.044355,"preClose":14.88,"low":14.43,"week52Low":7.55,"pbRate":"5.69","psRate":"16.38","week52High":18.51,"institutionHeld":0,"latestPrice":14.88,"eps":0.079999,"divideRate":0,"volume":1550448,"delay":0,"ttmEps":0.079999,"open":14.79,"prevYearClose":10.55,"prevWeekClose":14.05,"prevMonthClose":12.58,"prevQuarterClose":12.58,"fiveDayClose":13.24,"twentyDayClose":14.31,"sixtyDayClose":13.55},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SPRY\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2526693877","title":"Ars Pharmaceuticals, Inc.盤中異動 早盤股價大漲5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526693877","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526693877?lang=zh_tw&edition=fundamental","pubTime":"2025-04-11 21:49","pubTimestamp":1744379358,"startTime":"0","endTime":"0","summary":"北京时间2025年04月11日21时49分，Ars Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.48%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.21%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Portage Biotech Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 涨幅较大，Conduit Pharmaceuticals Inc.、Hepion Pharmaceuticals, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为278.18%、204.02%、64.16%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Portage Biotech Inc.、Zyversa Therapeutics, Inc.，振幅分别为45.04%、39.41%、29.82%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041121491894d2fb5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041121491894d2fb5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2526313573","title":"Ars Pharmaceuticals, Inc.盤中異動 快速拉昇5.60%報13.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526313573","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526313573?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 01:20","pubTimestamp":1744219253,"startTime":"0","endTime":"0","summary":"北京时间2025年04月10日01时20分，Ars Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.60%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为2.06%。其相关个股中，Phio Pharmaceuticals Corp.、Hepion Pharmaceuticals, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Hepion Pharmaceuticals, Inc.、Phio Pharmaceuticals Corp.、Aditxt, Inc.较为活跃，换手率分别为7403.78%、2928.53%、225.37%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Moolec Science Sa C/Wts 、Hepion Pharmaceuticals, Inc.，振幅分别为138.61%、108.26%、80.93%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410012053a453f89c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410012053a453f89c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2526842727","title":"Ars Pharmaceuticals, Inc.盤中異動 急速下跌5.07%報12.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526842727","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526842727?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 03:12","pubTimestamp":1744139546,"startTime":"0","endTime":"0","summary":"北京时间2025年04月09日03时12分，Ars Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.07%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.08%。其相关个股中，60 Degrees Pharmaceuticals, Inc.、Zyversa Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，60 Degrees Pharmaceuticals, Inc.、Zyversa Therapeutics, Inc.、Onconetix, Inc.较为活跃，换手率分别为5319.83%、3973.32%、1163.46%，振幅较大的相关个股有Zyversa Therapeutics, Inc.、60 Degrees Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为228.52%、114.54%、90.79%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040903122694cfd6ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040903122694cfd6ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2521317222","title":"Ars Pharmaceuticals, Inc.2024財年實現淨利潤8.00百萬美元，同比增加114.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2521317222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521317222?lang=zh_tw&edition=fundamental","pubTime":"2025-03-22 00:00","pubTimestamp":1742572854,"startTime":"0","endTime":"0","summary":"3月22日，Ars Pharmaceuticals, Inc.公布财报，公告显示公司2024财年净利润为8.00百万美元，同比增加114.71%；其中营业收入为89.15百万美元，同比增加297066.67%，每股基本收益为0.08美元。从资产负债表来看，Ars Pharmaceuticals, Inc.总负债94.36百万美元，其中短期债务42000.00美元，资产负债比为0.04，流动比率为0.15。机构评级：截至2025年3月22日，当前有5家机构对Ars Pharmaceuticals, Inc.目标价做出预测，其中目标均价为30.80美元，其中最低目标价为26.00美元，最高目标价为40.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250322000108a43ce03f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250322000108a43ce03f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY"],"gpt_icon":0},{"id":"2520660874","title":"BUZZ-美國股市動態-KKR、Micron Technology、Eli Lilly","url":"https://stock-news.laohu8.com/highlight/detail?id=2520660874","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520660874?lang=zh_tw&edition=fundamental","pubTime":"2025-03-20 23:56","pubTimestamp":1742486210,"startTime":"0","endTime":"0","summary":".N美国东部时间11:30，道琼斯工业平均指数.DJI上涨0.42%，报42142.37点；标普500指数.SPX上涨0.37%，报5695.08，纳斯达克综合指数.IXIC上涨0.52%，报17,843.01点。标普500指数.PG.INX涨幅最大的三只股票： ** Darden Restaurants IncDRI.N，上涨5.9%. ** Zeekr Intelligent Technology Holding Ltd <ZK.N>，下跌9.6%. BUZZ——花旗将啤酒需求放缓评级下调至“中性”，导致股价下跌 nL4N3Q30PH  ** Akebia Therapeutics Inc AKBA.O：。BUZZ - 受与私营公司Betaliq合并计划影响而下跌   nL4N3Q30W2  ** Microchip Technology Inc MCHP.O：。BUZZ——同店销售额降幅低于预期后上涨   nL4N3Q30XJ  ** Elevation Oncology Inc ELEV.O：。BUZZ - Wells Fargo upgrades KKR to 'overweight',","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nL4T3Q319U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBL","LU0231483743.USD","BECN","LLY","BGSF","CVNA","MCHP","STZ","LU2764263203.CNY","ZK","LU2326559502.SGD","PSTV","SPRY","WINT","SCVL","LU1880383366.USD","EPAM","IE00B64PRP62.GBP","DRI","ELEV","VVPR","KKR","LU0882574055.USD","AKBA","YRD","SG9999017495.SGD","ASO","COTY","LU1564329032.USD","BKKT","SAG","CLDX","LU0348805143.USD","ACN","EYEN","RIVN","LU1366333091.USD","PRA","LU0985320562.USD","FIVE","OPTN","LU0633140560.USD","PII","NOVA","QXO","LU0058720904.USD","CNNE","LENZ"],"gpt_icon":1},{"id":"2520452248","title":"BUZZ-第四季度利潤意外增長，ARS Pharma股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2520452248","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520452248?lang=zh_tw&edition=fundamental","pubTime":"2025-03-20 21:53","pubTimestamp":1742478792,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nL4S3Q313K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"1127838724","title":"異動解讀 | ARS製藥盤中大漲20.34%，季度業績遠超預期","url":"https://stock-news.laohu8.com/highlight/detail?id=1127838724","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127838724?lang=zh_tw&edition=fundamental","pubTime":"2025-03-20 21:39","pubTimestamp":1742477968,"startTime":"0","endTime":"0","summary":"ARS制药今日盘中股价大涨20.34%，引发市场广泛关注。根据公司公布的财报，ARS制药2024年第四季度实现每股收益0.48美元，远超分析师预期的亏损0.14美元，超出幅度高达442.86%。这份亮眼的财报显示了ARS制药强劲的业务增长和盈利能力，极大地提振了投资者信心。作为生物制药行业的新秀，ARS制药的优异表现不仅反映了公司自身的经营实力，也为整个行业的发展前景带来了积极信号。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SPRY"],"gpt_icon":0},{"id":"2520454217","title":"ARS Pharmaceuticals Inc.公佈截至12月31日的季度業績——收益彙總","url":"https://stock-news.laohu8.com/highlight/detail?id=2520454217","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520454217?lang=zh_tw&edition=fundamental","pubTime":"2025-03-20 21:31","pubTimestamp":1742477517,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals Inc.公布截至12月31日的季度业绩——收益汇总ARS Pharmaceuticals Inc SPRY.OQ公布的截至12月31日的季度调整后每股收益为49美分，高于去年同期的每股收益-7美分。ARS Pharmaceuticals Inc.公布的本季度每股收益为49美分。该公司公布的季度净收入为4993万美元。ARS Pharmaceuticals Inc的股价本季度上涨了10.4%。生物技术和医学研究同行组的平均共识推荐也是“强烈买入”华尔街对ARS Pharmaceuticals Inc的12个月目标价中位数为31.50美元 本摘要是机器根据伦敦证券交易所集团数据于世界协调时 3 月 20 日下午 1:31 生成的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nL4S3Q310R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2520727458","title":"ARS Pharmaceuticals(SPRY.US)：2024年Q4財報實現營收8660萬美元，前值為0美元，預期值為1590萬美元；每股收益為0.48美元，前值為-0.07美元，預期值為-0.12美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2520727458","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520727458?lang=zh_tw&edition=fundamental","pubTime":"2025-03-20 19:42","pubTimestamp":1742470961,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals(SPRY.US)：2024年Q4财报实现营收8660万美元，前值为0美元，预期值为1590万美元；每股收益为0.48美元，前值为-0.07美元，预期值为-0.12美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/20194248906677.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["SPRY"],"gpt_icon":0},{"id":"1141239072","title":"異動解讀 | ARS製藥公司業績超預期，股價盤前大漲9.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=1141239072","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141239072?lang=zh_tw&edition=fundamental","pubTime":"2025-03-20 19:18","pubTimestamp":1742469524,"startTime":"0","endTime":"0","summary":"ARS制药公司今日盘前大涨9.44%，引起投资者广泛关注。这一显著涨幅主要源于公司最新发布的季度财报大幅超出市场预期。根据公司公布的2024年第四季度财报，ARS制药公司实现每股收益0.48美元，远超分析师预期的亏损0.14美元，超出幅度高达442.86%。这份亮眼的财报显示了ARS制药公司强劲的业务增长和盈利能力，极大地提振了投资者信心。随着市场对公司未来发展预期的提升，投资者对ARS制药股票的追捧推动了其盘前股价的大幅上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SPRY"],"gpt_icon":0},{"id":"1163535667","title":"ARS Pharmaceuticals 2024年第四季度非GAAP每股收益為0.48美元，可能與-(0.14)美元預期不具可比性，銷售額為86.60百萬美元，可能與15.82百萬美元預期不具可比性","url":"https://stock-news.laohu8.com/highlight/detail?id=1163535667","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163535667?lang=zh_tw&edition=fundamental","pubTime":"2025-03-20 19:06","pubTimestamp":1742468763,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals报告季度每股收益为0.48美元，超出分析师共识预期的-美元442.86%。这比去年同期-美元的亏损增长了785.71%。公司报告季度销售额为86.60百万美元，超出分析师共识预期的15.82百万美元447.48%。以上内容来自Benzinga Earnings专栏，原文如下：ARS Pharmaceuticals  reported quarterly earnings of $0.48 per share which beat the analyst consensus estimate of $ by 442.86 percent. This is a 785.71 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $86.60 million which beat the analyst consensus estimate of $15.82 million ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"ARS Pharmaceuticals 2024年第四季度非GAAP每股收益为0.48美元，可能与-(0.14)美元预期不具可比性，销售额为86.60百万美元，可能与15.82百万美元预期不具可比性","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY"],"gpt_icon":0},{"id":"2517461243","title":"ARS Pharmaceuticals(SPRY.US)獲Scotiabank首次覆蓋，給予跑贏大盤評級, 目標價30.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517461243","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517461243?lang=zh_tw&edition=fundamental","pubTime":"2025-03-08 06:25","pubTimestamp":1741386325,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals(SPRY.US)获Scotiabank首次覆盖，给予跑赢大盘评级, 目标价30.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08062548605319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["SPRY"],"gpt_icon":0},{"id":"2517645691","title":"嗡嗡聲--美國股票走勢-CoreCivic、Teladoc、Dynavax","url":"https://stock-news.laohu8.com/highlight/detail?id=2517645691","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517645691?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 23:41","pubTimestamp":1741275687,"startTime":"0","endTime":"0","summary":".N美东时间 10:30，道琼斯工业平均指数.DJI下跌 0.53%，报 42776.97 点。标准普尔500指数.SPX下跌0.79%，报5796.28点；纳斯达克综合指数.IXIC下跌0.87%，报18390.40点。标准普尔 500 指数.PG.INX涨幅前三名是： ** Mosaic Co MOS.N，上涨 3.8. ** Fastenal Co FAST.OQ，上涨 2.6 标准普尔500指数.PL.INX跌幅前三名： ** Moderna Inc MRNA.OQ，下跌 4.5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nL3T3PP1DD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTSG","LU2023250843.SGD","IE00BJTD4N35.SGD","HUT","LU0149725797.USD","IBRX","LU1496350171.SGD","SCNX","LU1366192091.USD","MDB","CPB","ALGM","TDOC","BURL","BK4560","IE00BJTD4V19.USD","LU0820561818.USD","LU1223082196.USD","CXW","NEM","HTGC","LU1699723380.USD","VG","ZS","VSCO","DVAX","BAC","CZR","KBH","MOS","LU1267930573.SGD","BK4543","LEN","LU2552382215.SGD","FAST","LU0648001328.SGD","LULU","IE00BKVL7J92.USD","KR","SPRY","PHM","DHI","FCX"],"gpt_icon":1},{"id":"2517168946","title":"嗡嗡聲--美國股票走勢-Scienture、ARS Pharma、BrightSpring Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2517168946","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517168946?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 22:09","pubTimestamp":1741270162,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nL3T3PP14V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4560","IE00BHPRN162.USD","LU0320765489.SGD","VSCO","IE00BBT3K403.USD","LU2360107168.USD","LU2237443978.SGD","NEM","CPB","LU2750360997.AUD","FCX","LU0648001328.SGD","BAC","BK4604","SPRY","LU1506573853.SGD","LU2028103732.USD","LU0048584097.USD","LU1732800096.USD","LU1914381329.SGD","LU2471134523.USD","BTSG","SCNX","LU2089284900.SGD","IBRX","IE00B7SZLL34.SGD","LU2756315318.SGD","IE00BMPRXN33.USD","MDB","ZS","LU0971096721.USD","LU1244550577.SGD","LU2125909916.SGD","IE00BZ1G4Q59.USD","BURL","LU0082616367.USD","KKR","LU1989764748.USD","LU2237438978.USD","LU2498475776.HKD","LU0708994859.HKD","LU0330918003.SGD","LU2430703251.USD","ALGM","IE00B64PRP62.GBP","LU1883839398.USD","LU0788109121.HKD","LU0719512351.SGD"],"gpt_icon":1},{"id":"2517157452","title":"BUZZ-ARS Pharma 因過敏反應鼻噴霧劑在美國獲批範圍擴大而上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2517157452","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517157452?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 21:38","pubTimestamp":1741268283,"startTime":"0","endTime":"0","summary":"** Neffy 设计用于在出现严重过敏反应的第一个迹象时使用，之前已获准用于体重超过 30 公斤的患者，剂量为 2 毫克。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nL3S3PP12O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2517921276","title":"美國 FDA 擴大 ARS 製藥公司過敏反應鼻噴霧劑在 15-30 公斤患者中的使用範圍","url":"https://stock-news.laohu8.com/highlight/detail?id=2517921276","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517921276?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 05:21","pubTimestamp":1741209699,"startTime":"0","endTime":"0","summary":"更新版 2-美国 FDA 扩大 ARS 制药公司过敏反应鼻喷雾剂在 15-30 公斤患者中的使用范围第 7-9 段增加了分析师评论；第 11 和 12 段增加了首席执行官评论，并在全文中提供了详细信息Christy Santhosh路透社3月5日 - 美国食品和药物管理局批准扩大ARS制药公司SPRY.O鼻腔喷雾剂的使用范围，用于体重在15至30公斤之间的严重过敏反应患者。ARS 表示，neffy 1 毫克有望于 5 月底在美国上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL3S3PO1U4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2087621335.USD","SPRY","BK4139","BK4583","BK4588","VTRS","LU1839511570.USD","BK4007","BK4585"],"gpt_icon":0},{"id":"2517921146","title":"美國 FDA 擴大過敏反應鼻腔噴霧劑在 15-30 公斤體重人羣中的使用範圍","url":"https://stock-news.laohu8.com/highlight/detail?id=2517921146","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517921146?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 05:14","pubTimestamp":1741209261,"startTime":"0","endTime":"0","summary":"美国 FDA 扩大过敏反应鼻腔喷雾剂在 15-30 公斤体重人群中的使用范围路透社3月5日 - 美国食品和药物管理局批准扩大ARS制药公司SPRY.O鼻腔喷雾剂的使用范围，用于体重在15至30公斤之间的严重过敏反应患者。 (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL3S3PO1TO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY","BK4588","BK4007","VTRS","BK4583","LU1839511570.USD","BK4585","LU2087621335.USD"],"gpt_icon":0},{"id":"2517398688","title":"Ars Pharmaceuticals, Inc.盤中異動 下午盤股價大漲5.01%報10.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517398688","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517398688?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 04:18","pubTimestamp":1741119485,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日04时18分，Ars Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.01%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305041805abe85197&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305041805abe85197&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2514385185","title":"Ars Pharmaceuticals, Inc.盤中異動 早盤股價大漲5.57%報10.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385185","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514385185?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 22:31","pubTimestamp":1740666704,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时31分，Ars Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.57%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Quoin Pharmaceuticals Ltd涨幅较大，Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为405.81%、90.91%、50.39%，振幅较大的相关个股有Pds Biotechnology Corporation、天演药业、Syros Pharmaceuticals, Inc.，振幅分别为11.69%、10.10%、10.09%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223144abdf6e9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223144abdf6e9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2513377332","title":"Ars Pharmaceuticals, Inc.盤中異動 股價大跌5.16%報10.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513377332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513377332?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 23:31","pubTimestamp":1740411117,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时31分，Ars Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.16%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Pepgen Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为205.96%、86.70%、27.91%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为137.23%、55.69%、53.34%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224233158a25222ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224233158a25222ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRY"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":57,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SPRY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-20","symbol":"SPRY","fiscalQuarterEnding":"2024/12","expectedEps":-0.04,"name":null,"time":"盤前","type":"earning","dateTimestamp":1742443200000,"reportTimeType":"pre","actualEps":0.52},{"market":"US","date":"2025-01-13","symbol":"SPRY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1736744400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-11-13","symbol":"SPRY","fiscalQuarterEnding":"2024/09","expectedEps":-0.18,"name":null,"time":"盤前","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.2},{"market":"US","date":"2024-08-06","symbol":"SPRY","fiscalQuarterEnding":"2024/06","expectedEps":-0.12,"name":null,"time":"盤後","type":"earning","dateTimestamp":1722916800000,"reportTimeType":"post","actualEps":-0.13},{"market":"US","date":"2024-05-09","symbol":"SPRY","fiscalQuarterEnding":"2024/03","expectedEps":-0.11,"name":null,"time":"盤後","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":-0.11}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SPRY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SPRY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0.3333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":6,"updateTime":1741320000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SPRY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SPRY","date":"2025-04-17","current":182.548472,"percent":0.998246,"low":-41.829007,"twenty":-28.599098,"median":-17.719962,"eighty":-12.05734,"high":183.897957,"avg":-13.810091,"sd":34.67445,"marketCap":1460022683},"quantilePoints":[{"date":"2022-11-11","current":-28.534516,"twenty":-28.349227,"median":-28.071294,"eighty":-27.904534,"marketCap":577624216},{"date":"2022-11-18","current":-27.515427,"twenty":-28.349227,"median":-28.00181,"eighty":-27.867476,"marketCap":556994780},{"date":"2022-11-25","current":-28.627161,"twenty":-29.164499,"median":-28.302905,"eighty":-27.978649,"marketCap":579499619},{"date":"2022-12-02","current":-32.332942,"twenty":-29.813011,"median":-28.534516,"eighty":-27.978649,"marketCap":654515751},{"date":"2022-12-09","current":-33.352032,"twenty":-32.629404,"median":-28.951417,"eighty":-27.987913,"marketCap":675145188},{"date":"2022-12-16","current":-37.428392,"twenty":-33.870842,"median":-29.970507,"eighty":-28.034236,"marketCap":757662933},{"date":"2022-12-23","current":-37.428392,"twenty":-36.761351,"median":-31.221208,"eighty":-28.136145,"marketCap":757662933},{"date":"2022-12-30","current":-39.512894,"twenty":-37.428392,"median":-32.842487,"eighty":-28.39555,"marketCap":799859507},{"date":"2023-01-06","current":-33.490999,"twenty":-37.558094,"median":-33.236227,"eighty":-28.506723,"marketCap":677958292},{"date":"2023-01-13","current":-34.510089,"twenty":-37.428392,"median":-33.352032,"eighty":-28.608632,"marketCap":698587729},{"date":"2023-01-20","current":-24.704541,"twenty":-37.261632,"median":-32.981454,"eighty":-28.089644,"marketCap":627322403},{"date":"2023-01-27","current":-23.338221,"twenty":-36.955904,"median":-32.518231,"eighty":-27.978649,"marketCap":592627442},{"date":"2023-02-03","current":-26.292426,"twenty":-36.631648,"median":-30.109473,"eighty":-26.233342,"marketCap":667643574},{"date":"2023-02-10","current":-28.323442,"twenty":-36.44636,"median":-29.576768,"eighty":-26.233342,"marketCap":719217165},{"date":"2023-02-17","current":-31.868488,"twenty":-36.103575,"median":-29.970507,"eighty":-27.026227,"marketCap":809236523},{"date":"2023-02-24","current":-30.539096,"twenty":-35.51065,"median":-30.109473,"eighty":-27.543213,"marketCap":775479264},{"date":"2023-03-03","current":-33.641011,"twenty":-34.760229,"median":-30.612951,"eighty":-27.668279,"marketCap":854246203},{"date":"2023-03-10","current":-29.025066,"twenty":-34.306271,"median":-30.649879,"eighty":-27.867476,"marketCap":737033496},{"date":"2023-03-17","current":-31.056082,"twenty":-33.963486,"median":-30.631415,"eighty":-27.978649,"marketCap":788607087},{"date":"2023-03-24","current":-20.659679,"twenty":-33.801144,"median":-30.612951,"eighty":-27.867476,"marketCap":716518982},{"date":"2023-03-31","current":-17.719962,"twenty":-33.618064,"median":-30.576023,"eighty":-26.2038,"marketCap":614563712},{"date":"2023-04-06","current":-15.732931,"twenty":-33.565575,"median":-30.176574,"eighty":-25.70897,"marketCap":545649501},{"date":"2023-04-14","current":-16.631178,"twenty":-33.492841,"median":-29.970507,"eighty":-24.113699,"marketCap":576802501},{"date":"2023-04-21","current":-17.973502,"twenty":-33.463206,"median":-29.344076,"eighty":-23.419462,"marketCap":623356984},{"date":"2023-04-28","current":-17.210989,"twenty":-33.352032,"median":-29.090384,"eighty":-19.070054,"marketCap":596911536},{"date":"2023-05-05","current":-16.693286,"twenty":-33.350744,"median":-28.918758,"eighty":-18.073817,"marketCap":578956528},{"date":"2023-05-12","current":-12.329028,"twenty":-33.323434,"median":-28.627161,"eighty":-17.841072,"marketCap":427595344},{"date":"2023-05-19","current":-17.294264,"twenty":-33.212652,"median":-28.359496,"eighty":-17.789501,"marketCap":733155735},{"date":"2023-05-26","current":-17.057707,"twenty":-33.123305,"median":-28.101877,"eighty":-17.789501,"marketCap":723127390},{"date":"2023-06-02","current":-15.358643,"twenty":-33.120421,"median":-28.024971,"eighty":-17.719962,"marketCap":651098973},{"date":"2023-06-09","current":-15.179795,"twenty":-32.981454,"median":-27.978649,"eighty":-17.665522,"marketCap":643517035},{"date":"2023-06-16","current":-13.525443,"twenty":-32.939388,"median":-27.584891,"eighty":-17.230009,"marketCap":573384103},{"date":"2023-06-23","current":-14.352619,"twenty":-32.898926,"median":-26.292426,"eighty":-16.984823,"marketCap":608450569},{"date":"2023-06-30","current":-14.777385,"twenty":-32.852687,"median":-26.033933,"eighty":-16.443167,"marketCap":626457673},{"date":"2023-07-07","current":-14.374975,"twenty":-32.778571,"median":-25.664657,"eighty":-16.200645,"marketCap":609398311},{"date":"2023-07-14","current":-15.381,"twenty":-32.650157,"median":-24.815323,"eighty":-15.896248,"marketCap":652046716},{"date":"2023-07-20","current":-16.342312,"twenty":-32.522678,"median":-23.947525,"eighty":-15.738555,"marketCap":692799635},{"date":"2023-07-28","current":-14.889165,"twenty":-32.268091,"median":-23.449004,"eighty":-15.666005,"marketCap":631196385},{"date":"2023-08-04","current":-15.649273,"twenty":-31.980646,"median":-22.434463,"eighty":-15.664922,"marketCap":663419624},{"date":"2023-08-11","current":-12.27233,"twenty":-31.772476,"median":-20.321699,"eighty":-15.577733,"marketCap":654642902},{"date":"2023-08-18","current":-12.05734,"twenty":-31.358888,"median":-18.902086,"eighty":-15.443597,"marketCap":643174706},{"date":"2023-08-25","current":-12.361909,"twenty":-31.218563,"median":-18.499284,"eighty":-15.287104,"marketCap":659421318},{"date":"2023-08-30","current":-12.70231,"twenty":-31.152094,"median":-18.359623,"eighty":-15.152968,"marketCap":677579296},{"date":"2023-09-08","current":-13.114373,"twenty":-31.100395,"median":-18.231502,"eighty":-15.005417,"marketCap":699560007},{"date":"2023-09-15","current":-13.04271,"twenty":-31.033926,"median":-18.031385,"eighty":-14.777385,"marketCap":695737274},{"date":"2023-09-20","current":-11.833393,"twenty":-31.022847,"median":-18.002563,"eighty":-14.750557,"marketCap":631228667},{"date":"2023-09-27","current":-6.718429,"twenty":-31.011769,"median":-17.988032,"eighty":-14.670075,"marketCap":358381151},{"date":"2023-10-05","current":-7.166324,"twenty":-30.867751,"median":-17.964938,"eighty":-14.419687,"marketCap":382273228},{"date":"2023-10-13","current":-6.718429,"twenty":-30.668342,"median":-17.875755,"eighty":-14.196126,"marketCap":358381151},{"date":"2023-10-20","current":-6.055544,"twenty":-30.649879,"median":-17.782874,"eighty":-14.047454,"marketCap":323020877},{"date":"2023-10-27","current":-6.306365,"twenty":-30.649879,"median":-17.728408,"eighty":-14.012806,"marketCap":336400440},{"date":"2023-11-03","current":-6.539271,"twenty":-30.635108,"median":-17.710569,"eighty":-13.713234,"marketCap":348824320},{"date":"2023-11-10","current":-5.319172,"twenty":-30.612951,"median":-17.665522,"eighty":-13.225451,"marketCap":327799293},{"date":"2023-11-17","current":-7.025405,"twenty":-30.612951,"median":-17.36121,"eighty":-12.859969,"marketCap":432947606},{"date":"2023-11-24","current":-7.41484,"twenty":-30.59818,"median":-17.220775,"eighty":-12.627063,"marketCap":456946919},{"date":"2023-12-01","current":-7.523882,"twenty":-30.480012,"median":-17.057707,"eighty":-12.494486,"marketCap":463666727},{"date":"2023-12-08","current":-8.1314,"twenty":-30.216835,"median":-16.553813,"eighty":-12.335604,"marketCap":501105655},{"date":"2023-12-15","current":-8.115823,"twenty":-30.090944,"median":-16.431736,"eighty":-12.243664,"marketCap":500145682},{"date":"2023-12-22","current":-7.944471,"twenty":-30.007565,"median":-16.309818,"eighty":-8.996418,"marketCap":489585985},{"date":"2023-12-29","current":-8.770073,"twenty":-29.979771,"median":-16.222884,"eighty":-8.287174,"marketCap":540464528},{"date":"2024-01-05","current":-8.785651,"twenty":-29.917293,"median":-16.174641,"eighty":-8.399331,"marketCap":541424501},{"date":"2024-01-12","current":-9.112776,"twenty":-29.704533,"median":-16.005127,"eighty":-8.58626,"marketCap":561583924},{"date":"2024-01-19","current":-9.471056,"twenty":-29.440705,"median":-15.977907,"eighty":-8.629876,"marketCap":583663292},{"date":"2024-01-26","current":-10.156461,"twenty":-29.180978,"median":-15.857321,"eighty":-8.707763,"marketCap":625902083},{"date":"2024-02-02","current":-9.969533,"twenty":-29.156298,"median":-15.732931,"eighty":-8.773189,"marketCap":614382412},{"date":"2024-02-09","current":-10.109729,"twenty":-29.07732,"median":-15.682807,"eighty":-8.798113,"marketCap":623022165},{"date":"2024-02-16","current":-11.309188,"twenty":-29.025066,"median":-15.649273,"eighty":-8.900923,"marketCap":696940049},{"date":"2024-02-23","current":-11.83882,"twenty":-29.025066,"median":-15.515136,"eighty":-9.112776,"marketCap":729579115},{"date":"2024-03-01","current":-13.038279,"twenty":-28.81245,"median":-15.453657,"eighty":-9.20624,"marketCap":803496999},{"date":"2024-03-08","current":-13.941768,"twenty":-28.8035,"median":-15.381,"eighty":-9.20624,"marketCap":859175405},{"date":"2024-03-15","current":-14.019655,"twenty":-28.627161,"median":-15.258041,"eighty":-9.237395,"marketCap":863975268},{"date":"2024-03-22","current":-15.975609,"twenty":-28.534516,"median":-15.179795,"eighty":-9.252972,"marketCap":868513986},{"date":"2024-03-28","current":-17.679674,"twenty":-28.423343,"median":-15.269219,"eighty":-9.315282,"marketCap":961155477},{"date":"2024-04-05","current":-16.916395,"twenty":-28.337864,"median":-15.369822,"eighty":-9.405631,"marketCap":919659809},{"date":"2024-04-12","current":-16.401625,"twenty":-28.264358,"median":-15.43689,"eighty":-9.46171,"marketCap":891674358},{"date":"2024-04-19","current":-14.981571,"twenty":-28.131419,"median":-15.49278,"eighty":-9.483518,"marketCap":814473115},{"date":"2024-04-26","current":-14.360297,"twenty":-28.077411,"median":-15.403356,"eighty":-9.636176,"marketCap":780697571},{"date":"2024-05-03","current":-16.860498,"twenty":-28.034236,"median":-15.420123,"eighty":-9.72341,"marketCap":916620967},{"date":"2024-05-10","current":-17.157732,"twenty":-27.987913,"median":-15.505955,"eighty":-9.779488,"marketCap":852670667},{"date":"2024-05-17","current":-17.742813,"twenty":-27.978649,"median":-15.537492,"eighty":-9.809086,"marketCap":881746829},{"date":"2024-05-24","current":-17.157885,"twenty":-27.978649,"median":-15.649273,"eighty":-9.876069,"marketCap":852678252},{"date":"2024-05-31","current":-17.372359,"twenty":-27.867476,"median":-15.716341,"eighty":-9.910338,"marketCap":863336730},{"date":"2024-06-07","current":-17.19688,"twenty":-27.668279,"median":-15.746992,"eighty":-9.932147,"marketCap":854616157},{"date":"2024-06-14","current":-17.430851,"twenty":-27.557105,"median":-15.857321,"eighty":-9.95084,"marketCap":866243588},{"date":"2024-06-21","current":-15.071642,"twenty":-27.270827,"median":-15.857321,"eighty":-9.975764,"marketCap":749000328},{"date":"2024-06-28","current":-15.695565,"twenty":-26.781626,"median":-15.857321,"eighty":-9.988225,"marketCap":780006810},{"date":"2024-07-05","current":-17.723315,"twenty":-26.233342,"median":-15.924221,"eighty":-10.038073,"marketCap":880777877},{"date":"2024-07-12","current":-21.66183,"twenty":-26.100403,"median":-16.005127,"eighty":-10.100383,"marketCap":1076506294},{"date":"2024-07-15","current":-22.129772,"twenty":-26.078246,"median":-16.005127,"eighty":-10.103498,"marketCap":1099761155},{"date":"2024-08-02","current":-20.452979,"twenty":-26.05609,"median":-16.005127,"eighty":-10.106614,"marketCap":1016431235},{"date":"2024-08-09","current":-21.380681,"twenty":-25.915765,"median":-16.072487,"eighty":-10.122191,"marketCap":958752513},{"date":"2024-08-16","current":-29.271428,"twenty":-26.174258,"median":-16.163463,"eighty":-10.15023,"marketCap":1312589385},{"date":"2024-08-23","current":-27.693279,"twenty":-27.713295,"median":-16.214626,"eighty":-10.468009,"marketCap":1241822011},{"date":"2024-08-30","current":-28.060793,"twenty":-27.98643,"median":-16.295121,"eighty":-10.844982,"marketCap":1258302084},{"date":"2024-09-06","current":-25.401719,"twenty":-27.994212,"median":-16.393243,"eighty":-10.985179,"marketCap":1139063905},{"date":"2024-09-13","current":-27.304146,"twenty":-27.978649,"median":-16.401625,"eighty":-11.047488,"marketCap":1224372521},{"date":"2024-09-20","current":-32.125068,"twenty":-28.0393,"median":-16.454093,"eighty":-11.125375,"marketCap":1440552309},{"date":"2024-09-27","current":-31.368421,"twenty":-28.102738,"median":-16.474539,"eighty":-11.25311,"marketCap":1406622746},{"date":"2024-10-04","current":-30.265879,"twenty":-28.279129,"median":-16.592455,"eighty":-11.496117,"marketCap":1357182526},{"date":"2024-10-11","current":-30.071312,"twenty":-28.572704,"median":-16.658407,"eighty":-11.620736,"marketCap":1348457781},{"date":"2024-10-18","current":-34.870616,"twenty":-28.814446,"median":-16.809891,"eighty":-11.676815,"marketCap":1563668153},{"date":"2024-10-25","current":-33.292466,"twenty":-29.051193,"median":-16.869409,"eighty":-11.785716,"marketCap":1492900778},{"date":"2024-10-31","current":-30.849578,"twenty":-29.236068,"median":-16.900657,"eighty":-11.835564,"marketCap":1383356760},{"date":"2024-11-08","current":-34.892234,"twenty":-29.613,"median":-17.040899,"eighty":-11.890396,"marketCap":1564637569},{"date":"2024-11-15","current":-27.926178,"twenty":-29.784002,"median":-17.157809,"eighty":-12.003593,"marketCap":1371287052},{"date":"2024-11-22","current":-26.481379,"twenty":-29.677856,"median":-17.19688,"eighty":-12.129003,"marketCap":1300341655},{"date":"2024-11-29","current":-28.717849,"twenty":-29.625971,"median":-17.210989,"eighty":-12.243664,"marketCap":1410161242},{"date":"2024-12-06","current":-27.708469,"twenty":-29.56544,"median":-17.223194,"eighty":-12.275913,"marketCap":1360596650},{"date":"2024-12-13","current":-25.016789,"twenty":-29.525705,"median":-17.313866,"eighty":-12.298002,"marketCap":1228424404},{"date":"2024-12-20","current":-22.404276,"twenty":-29.458385,"median":-17.352861,"eighty":-12.329028,"marketCap":1100139577},{"date":"2024-12-27","current":-22.067816,"twenty":-29.271428,"median":-17.394358,"eighty":-12.329028,"marketCap":1083618046},{"date":"2025-01-03","current":-21.196979,"twenty":-29.200708,"median":-17.429503,"eighty":-12.355333,"marketCap":1040856437},{"date":"2025-01-10","current":-22.621986,"twenty":-29.176877,"median":-17.469847,"eighty":-12.383408,"marketCap":1110829979},{"date":"2025-01-17","current":-24.106368,"twenty":-29.123341,"median":-17.508842,"eighty":-12.41924,"marketCap":1183719085},{"date":"2025-01-24","current":-27.490759,"twenty":-29.064257,"median":-17.592246,"eighty":-12.455071,"marketCap":1349906247},{"date":"2025-01-31","current":-28.28243,"twenty":-29.064257,"median":-17.626125,"eighty":-12.501652,"marketCap":1388780437},{"date":"2025-02-07","current":-25.333457,"twenty":-29.025066,"median":-17.679674,"eighty":-12.537484,"marketCap":1243974080},{"date":"2025-02-14","current":-23.591782,"twenty":-29.002547,"median":-17.701176,"eighty":-12.573316,"marketCap":1158450862},{"date":"2025-02-21","current":-23.314697,"twenty":-28.938503,"median":-17.719962,"eighty":-12.598398,"marketCap":1144844895},{"date":"2025-02-28","current":-20.187599,"twenty":-28.816442,"median":-17.723315,"eighty":-12.627063,"marketCap":991291845},{"date":"2025-03-07","current":-21.355313,"twenty":-28.81066,"median":-17.742813,"eighty":-12.687977,"marketCap":1048631275},{"date":"2025-03-14","current":-23.651157,"twenty":-28.793317,"median":-17.742813,"eighty":-12.709476,"marketCap":1161366426},{"date":"2025-03-21","current":175.555688,"twenty":-28.745638,"median":-17.756493,"eighty":-12.709476,"marketCap":1404094395},{"date":"2025-03-28","current":154.945377,"twenty":-28.717849,"median":-17.742813,"eighty":-12.566149,"marketCap":1239253124},{"date":"2025-04-04","current":164.39177,"twenty":-28.699711,"median":-17.73561,"eighty":-12.404907,"marketCap":1314805373},{"date":"2025-04-11","current":162.428883,"twenty":-28.621548,"median":-17.723315,"eighty":-12.298002,"marketCap":1299106204},{"date":"2025-04-17","current":182.548472,"twenty":-28.599098,"median":-17.719962,"eighty":-12.05734,"marketCap":1460022683}],"updateTime":1745024309576}}}